In the news | 16th May 2022
Want to avoid biotech's newest bottleneck? Design your digital strategy early on.
In the quest to develop the science and raise funding, developing a digital strategy in general is an afterthought for fledgling biotech companies – if it’s considered at all. Not paying attention to it early, however, can hamper their ability to advance their science and constrain their revenue-generation options.
Read more in this article featuring Matt Clifford, IDBS, published in BioSpace.